MyFinsight
Home
Blog
About
logo
IDEXX LABORATORIES INC DE (IDXX)
logo
IDEXX LABORATORIES INC DE (IDXX)
Income Statement
|
Cash Flow
|
Balance Sheet
|
Ratios
Cash Flow Overview
Change in Cash
$43,572K
Free Cash flow
$371,226K
Unit: Thousand (K) dollars
Positive Cash Flow Breakdown
Net income
Deferred income taxes
Proceeds from exercises of stock...
Others
Negative Cash Flow Breakdown
Repurchases of common stock
Borrowings under credit facility...
Purchases of property and equipm...
Others
Subscribe for Financial Insights
Page 1
Quarterly
123
Page 1
Cash Flow
2025-09-30
2025-06-30
2025-03-31
2024-12-31
Net income
274,610
293,989
242,677
216,149
Depreciation and amortization
36,627
35,772
34,063
33,706
Impairment charge
0
0
0
0
Provision for credit losses
1,619
1,470
2,890
1,787
Deferred income taxes
93,248
2,479
3,948
-24,194
Share-based compensation expense
14,433
14,854
14,615
14,258
Other
1,753
1,035
456
184
Accounts receivable
7,697
29,649
45,240
-27,807
Inventories
-1,879
6,244
-2,163
3,245
Other assets and liabilities
21,038
129,581
10,325
35,393
Accounts payable
7,136
-3,990
-8,123
5,739
Deferred revenue
-230
5,608
838
-3,643
Net cash provided by operating activities
402,340
185,743
237,962
262,025
Purchases of property and equipment
31,114
34,102
30,026
29,255
Acquisition of intangible assets
13,350
-
-
10,000
Equity investments
756
-
-
1,004
Acquisition of a business
0
0
0
0
Proceeds from net investment hedges
349
474
416
416
Net cash used by investing activities
-44,871
-33,628
-29,610
-39,843
Borrowings under credit facility, net
-124,000
259,500
69,500
0
Payments of senior notes
0
103,386
-
0
Debt issuance costs
-
-
-
0
Repurchases of common stock
240,195
338,105
400,890
245,992
Proceeds from exercises of stock options and employee stock purchase plans
50,970
17,330
7,193
13,255
Payments of acquisition-related contingent consideration and holdbacks
-
-
-
0
Shares withheld for statutory tax withholding payments on restricted stock
85
970
6,124
45
Net cash used by financing activities
-313,310
-165,631
-330,321
-232,782
Net effect of changes in exchange rates on cash
-587
14,140
-2,327
-9,770
Net decrease in cash and cash equivalents
43,572
624
-124,296
-20,370
Cash and cash equivalents at beginning of period
163,970
163,970
288,266
397,433
Cash and cash equivalents at end of period
208,166
164,594
163,970
288,266
Page 1
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.
Page 1
Buy us a coffee
Time Plot
Show the time plot by selecting a row from the table.
Cash Flow
Net income
$274,610K
(17.94%↑ Y/Y)
Deferred income taxes
$93,248K
(1461.48%↑ Y/Y)
Depreciation and
amortization
$36,627K
(7.31%↑ Y/Y)
Share-based compensation
expense
$14,433K
(-9.33%↓ Y/Y)
Accounts payable
$7,136K
(590.45%↑ Y/Y)
Inventories
-$1,879K
(-110.13%↓ Y/Y)
Other
$1,753K
(2516.42%↑ Y/Y)
Provision for credit
losses
$1,619K
(21.09%↑ Y/Y)
Net cash provided by
operating activities
$402,340K
(82.82%↑ Y/Y)
Canceled cashflow
$28,965K
Net decrease in cash
and cash...
$43,572K
(146.87%↑ Y/Y)
Canceled cashflow
$358,768K
Other assets and
liabilities
$21,038K
(-67.16%↓ Y/Y)
Accounts receivable
$7,697K
(128.62%↑ Y/Y)
Deferred revenue
-$230K
(-10.05%↓ Y/Y)
Proceeds from exercises
of stock options...
$50,970K
(920.22%↑ Y/Y)
Proceeds from net
investment hedges
$349K
(-15.90%↓ Y/Y)
Net cash used by
financing activities
-$313,310K
(-7.67%↓ Y/Y)
Net cash used by
investing activities
-$44,871K
(-63.95%↓ Y/Y)
Net effect of
changes in exchange...
-$587K
(-111.05%↓ Y/Y)
Canceled cashflow
$50,970K
Canceled cashflow
$349K
Repurchases of common stock
$240,195K
(8.81%↑ Y/Y)
Borrowings under credit
facility, net
-$124,000K
Purchases of property and
equipment
$31,114K
(10.77%↑ Y/Y)
Acquisition of intangible
assets
$13,350K
Equity investments
$756K
Shares withheld for
statutory tax withholding...
$85K
(-61.01%↓ Y/Y)
Buy us a coffee